Dr. Lewis L. Shi is leading an active shoulder research program, with multiple clinical and translational projects. In collaboration with Dr. T.-C. He, he is investigating biological factors that may improve the healing of rotator cuff injuries. He has an on-going IRB approved study examining patients undergoing shoulder arthroscopy, correlating the growth factors of the subacromial milieu to the condition and chronicity of cuff tears. The ultimate goal is to identify potential pharmacologic treatment to augment rotator cuff repairs in human patients.
Dr. Shi is leading several multi-centered shoulder clinical outcome studies. These are prospective randomized control trials studying the optimal methods of treatment for rotator cuff tears, biceps tendonitis, and labrum tears. He is also conducting several studies using the Marketscan, a national insurance claims database, to examine the patterns, complications, and the cost of shoulder surgery in the last decade.
Dr. Shi continues his collaborations with the several prestigious orthopaedic hospitals in China. In this past year he has co-authored several papers in PLoS One and Genet Test Mol Biomarkers on ankylosing spondylitis with investigators in 301 Military Hospital in Beijing. Additionally his work on vascularized fibula graft with the Shanghai Sixth People’s Hospital has generated multiple podium presentations at international conferences and will be published soon.
Lewis Shi, MD
Associate Professor of Orthopedic Surgery and Rehabilitation Medicine